Education
About Us
Working with TipRanks
Follow Us
Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
6955 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$7.51 - HK$25.00
Previous CloseN/A
Volume154.80K
Average Volume (3M)25.14M
Market Cap
HK$8.55B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)96.3
Beta0.37
Next Earnings
Aug 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding574,333,700
10 Day Avg. Volume22,655,210
30 Day Avg. Volume25,143,969
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shandong Boan Biotechnology Company., Limited. Class H News
PremiumCompany Announcements
Shandong Boan Biotech Gains FDA Approval for BA1302 Clinical Trials
PremiumCompany Announcements
Shandong Boan Biotechnology Completes Share Placement to Fund R&D and Growth
PremiumCompany Announcements
Shandong Boan Biotechnology Announces AGM Results and Board Appointments
PremiumCompany Announcements
Shandong Boan Biotechnology Announces Board Composition and Roles
PremiumCompany Announcements
Shandong Boan Biotechnology Announces New Share Placement
PremiumCompany Announcements
Shandong Boan Biotechnology Announces 2025 AGM and Key ResolutionsPremiumCompany Announcements
Shandong Boan Biotechnology Proposes Amendments to Articles of AssociationOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.62% Public Companies and
Individual Investors
6955 FAQ
What was Shandong Boan Biotechnology Company., Limited. Class H’s price range in the past 12 months?
Shandong Boan Biotechnology Company., Limited. Class H lowest stock price was HK$7.51 and its highest was HK$25.00 in the past 12 months.
What is Shandong Boan Biotechnology Company., Limited. Class H’s market cap?
Shandong Boan Biotechnology Company., Limited. Class H’s market cap is HK$8.55B.
When is Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date?
Shandong Boan Biotechnology Company., Limited. Class H’s upcoming earnings report date is Aug 25, 2025 which is in 42 days.
How were Shandong Boan Biotechnology Company., Limited. Class H’s earnings last quarter?
Shandong Boan Biotechnology Company., Limited. Class H released its earnings results on Mar 27, 2025. The company reported HK$0.024 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.024.
Is Shandong Boan Biotechnology Company., Limited. Class H overvalued?
According to Wall Street analysts Shandong Boan Biotechnology Company., Limited. Class H’s price is currently Overvalued.
Does Shandong Boan Biotechnology Company., Limited. Class H pay dividends?
Shandong Boan Biotechnology Company., Limited. Class H does not currently pay dividends.
What is Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate?
Shandong Boan Biotechnology Company., Limited. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shandong Boan Biotechnology Company., Limited. Class H have?
Shandong Boan Biotechnology Company., Limited. Class H has 574,333,700 shares outstanding.
What happened to Shandong Boan Biotechnology Company., Limited. Class H’s price movement after its last earnings report?
Shandong Boan Biotechnology Company., Limited. Class H reported an EPS of HK$0.024 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.228%.
Which hedge fund is a major shareholder of Shandong Boan Biotechnology Company., Limited. Class H?
Currently, no hedge funds are holding shares in HK:6955
Shandong Boan Biotechnology Company., Limited. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.19%
12-Months-Change
Fundamentals
Return on Equity
4.95%
Trailing 12-Months
Asset Growth
18.62%
Trailing 12-Months
Company Description
Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialisation of high quality biologics in China and worldwide. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology.
Technical Analysis
Alphamab Oncology
―
Ascletis Pharma, Inc.
―
HBM Holdings Ltd.
―
Abbisko Cayman Limited
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―